Researchers developed a new formulation of doxorubicin that targets cancer cells while reducing cardiotoxicity. The protein-shell encapsulation increases specificity for cancer cells and decreases harm to healthy heart cells.
Researchers used a stem cell model to study the effects of Alzheimer's disease-associated mutations on early human brain development, finding that mutant spheres were larger and contained fewer mature neurons. The study highlights the need for tailored therapies and paves the way for studying Alzheimer's in its early stages.
Researchers have made progress in generating stem cell-derived beta cells, but current methods are costly and labor-intense. A recent study has found a simple method to address these issues, enhancing maturation and functionality of sBCs.
Researchers genetically engineered neural progenitor cells to release a neuroprotective protein, preventing neuron death in animal models of ALS and retinal disease. Engineered NPCs successfully preserved vision in rats with retinal disease.
Researchers have successfully converted pluripotent stem cells into hematopoietic stem and progenitor cells using optimized transcription factors. The resulting PSC-derived cells generated all types of white blood cells in mice without giving rise to tumors or leukemias, suggesting a promising future for PSC-based transplant therapies.
Researchers generated cochlear avatars from stem cells, recreating hair cell function and transmitting electrical signals. This breakthrough enables the investigation of sensorineural hearing loss mechanisms and potential treatments.
The ISSCR 2023 Annual Meeting will showcase the year's most compelling stem cell research and clinical breakthroughs. Attendees can participate in dedicated poster sessions and interact with presenters.
Researchers from Harvard University developed an efficient method to make large numbers of C4-secreting human astrocytes from stem cells. A small group of about 20 drugs were identified that reduced C4 secretion, effective in both healthy and Schizophrenia patients' astrocytes.
Researchers discovered stem cells in mouse dorsal root ganglia (DRG) with the potential to regenerate lost sensory neurons and glia. These cells, known as satellite glia, can become activated and generate new glia and, to a lesser extent, neurons after injury.
Researchers have successfully created dopaminergic neurons directly from the skin of patients with Parkinson's disease, preserving aged characteristics and cellular defects. This breakthrough allows for modeling PD-related neuronal defects in a larger cohort of patients, aiming to identify disease causes and potential therapies.
Researchers have created a stem cell-based model of the human liver, allowing for the study of how Ebola virus infects liver cells. The infected cultures showed that viral infection directly disrupts liver function, while immune cells can transfer the virus to other cells.
Researchers used human heart muscle cells and machine learning to predict arrhythmias in patients, achieving over 90% accuracy. The study lays the foundation for safer and more effective medicines by generating patient risk profiles and drug toxicity testing.
A recent study published in Stem Cell Reports found that sleep deprivation negatively affects corneal stem cells, leading to increased rates of cell multiplication and reduced tear film antioxidants. This can result in serious effects on corneal health, such as thinning and ruffling of the cornea.
Researchers have successfully generated large numbers of virus-resistant immune cells from monkeys using CRISPR/Cas9 gene editing. This breakthrough could lead to the development of a new treatment for HIV/AIDS by providing an alternative to current therapies that require lifelong medication and can cause side effects.
Researchers developed genetic modifications to increase stress resistance and immune evasion in stem cell-derived beta cells, leading to improved survival rates. The study suggests a potential breakthrough for treating type 1 diabetes through transplantation of these cells.
A recent study analyzed 59 US stem cell clinics and found that most rely on weakly scientifically credible marketing tactics, including technical descriptions of stem cells and patient testimonials. Only a minority invokes stronger forms of evidence, such as registered clinical trials or scientific peer-reviewed articles.
Stem cell researchers have developed a new method to identify and develop personalized therapies for Cystic Fibrosis patients with rare mutations. By growing precursor lung cells from patients' own blood, they can screen for new drugs and validate responses in mature airway cells.
Researchers developed lab-grown cochlear organoids to screen FDA-approved drugs for hair cell-inducing properties. The study identified Regorafenib as a potent stimulator of hair cell formation, even regenerating lost cells in mouse tissues.
Researchers found that astrocytes carrying the AD-associated APOE4 gene released more cholesterol, leading to increased beta-amyloid production in neurons. This study suggests modulating brain cholesterol could be a potential treatment option for Alzheimer's disease.
Researchers developed a sustainable source of corneal endothelial cells from pluripotent stem cells, reversing corneal transparency loss and promoting regrowth in rabbits and monkeys. The study suggests that stem cell-derived CECs may be a viable treatment option for patients with corneal endothelial dysfunction.
A new stem cell-based vaccine has demonstrated 75% protection against pancreatic cancer in a mouse study. The vaccine targets multiple antigens found on pancreatic cancer cells, potentially leading to a more durable immune response.
Researchers created mini-chambers on a microfluidic device where human motor neurons and skeletal muscle cells grew, forming neuromuscular junctions. The study found that ALS motor neurons formed fewer connections and regenerated axons less efficiently than healthy ones.
The International Society for Stem Cell Research (ISSCR) has launched a new podcast called The Stem Cell Report with Martin Pera, which delves into the inspiration and stories behind stem cell research. The podcast features interviews with leading researchers and experts in the field.
New research reveals sex-specific differences in brain stem cell activity and blood vessel density with age. Female mice show more efficient neurogenesis and better neuron migration compared to male mice, suggesting hormonal or genetic influences may play a role.
Researchers have successfully generated lab-grown mini-thyroid organs from patients' own thyroid tissue, which can produce thyroid hormones. The study provides a potentially unlimited source of lab-grown thyroid tissue and may lead to new therapy options for hypothyroidism.
Researchers found that quercetin and dihydroxybezoic acid from apples stimulate neurogenesis, generating new neurons and protecting against cell death. The effects on learning and memory are comparable to those seen after physical exercise.
A groundbreaking study by Liu et al successfully transplanted adult human eye stem cells into monkeys' eyes, restoring normal vision and supporting photoreceptor function. The retinal pigment epithelium-derived cells showed no serious side effects and integrated stably for at least three months.
A recent study used induced pluripotent stem cells to find drugs that enhance phagocytosis in the retinal pigment epithelium, a process critical for preventing vision loss. Several drugs showed promise, including Ramoplanin, which rescued defects in RPE from patients with a certain genetic form of RP.
Researchers have discovered that HSCs from early human embryos can multiply approximately 200-500 times more than those from umbilical cord blood, potentially revolutionizing blood cancer treatment. This breakthrough could lead to advances in expanding HSCs from bone marrow and cord blood, increasing the available blood supply.
Research finds that high androgen levels can cause intestinal stem cells to divide excessively and produce fewer mature epithelial cells, increasing the risk of tumor formation. The study's findings may have implications for treating or preventing colon cancers through androgen regulation.
The ISSCR is updating its guidelines to address the use of pluripotent stem cells in modeling early human embryo development. The new guidelines outline principles and recommendations for researchers, including oversight by special committees and reporting to Embryo Research Oversight (EMRO) processes.
Dr. Fred H. Gage has made groundbreaking discoveries in stem cell biology, neuroscience, and human evolution. His work has broad implications for treating diseases like Alzheimer's, Parkinson's, and mental health disorders.
Dr. Margaret A. Goodell, a renowned hematopoietic stem cell researcher, has been awarded the Tobias Lecture Award by the International Society for Stem Cell Research (ISSCR). Her pioneering work on epigenetic regulators of normal hematopoietic stem cell function has greatly advanced our understanding of hematologic malignancies.
Dr. Allon M. Klein receives the Dr. Susan Lim Award for his groundbreaking contributions to stem cell and developmental biology, including novel approaches to adult stem cell self-renewal and a cell-isolation system for transcriptional analysis.
Dr. Mitinori Saitou has made groundbreaking contributions to understanding mammalian germ cell development and reproduction in vitro. His work has enabled the generation of functional gametes from pluripotent stem cells and improved germ-cell technology.
Susan Solomon, CEO of The New York Stem Cell Foundation (NYSCF) Research Institute, receives the 2020 ISSCR Public Service Award for her tireless efforts to support stem cell science and researchers. NYSCF has raised over $350 million for stem cell research projects.
Scientists have developed a breakthrough culturing system for human liver stem cells and pancreatic cancer stem cells, allowing for the growth of mini-organisms in the lab. This technology has the potential to revolutionize liver transplantation and aid in the fight against pancreatic cancer, with applications in personalized medicine.
Azim Surani receives the McEwen Award for Innovation for pioneering epigenetics research; Valentina Greco wins the ISSCR-BD Biosciences Outstanding Young Investigator Award for her noninvasive method to visualize skin stem cell division. Paolo Bianco, Elena Cattaneo, and Michele De Luca receive the ISSCR Public Service Award for their ...